APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Drug Eluting Stent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Implantable Drug Eluting Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025192 pages

Choose your research edition.

Industry ResearchImplantable Drug Eluting Stent Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Drug Eluting Stent Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Implantable Drug Eluting Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Drug Eluting Stent Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Drug Eluting Stent Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Implantable Drug Eluting Stent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Implantable Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Implantable Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Implantable Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Implantable Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Implantable Drug Eluting Stent include Cook, Drug-eluting Stent, Terumo, Boston Scientific, Lepu Medical, Medtronic, Beijing Amsino Medical, SINOMED and Microport Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Implantable Drug Eluting Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Implantable Drug Eluting Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Implantable Drug Eluting Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Implantable Drug Eluting Stent market size, projected growth trends, production technologies, key applications, and end-use industries.

Implantable Drug Eluting Stent Segment by Company

Cook

Drug-eluting Stent

Terumo

Boston Scientific

Lepu Medical

Medtronic

Beijing Amsino Medical

SINOMED

Microport Medical

Abbott

Yinyi Biotech

Implantable Drug Eluting Stent Segment by Type

Rapamycin

Everolimus

Paclitaxel

Other

Implantable Drug Eluting Stent Segment by Application

Coronary

Peripheral Vascular

Others

Implantable Drug Eluting Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Drug Eluting Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Drug Eluting Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Drug Eluting Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Drug Eluting Stent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Implantable Drug Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Implantable Drug Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Implantable Drug Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Implantable Drug Eluting Stent Industry Trends Table 2. Implantable Drug Eluting Stent Industry Drivers Table 3. Implantable Drug Eluting Stent Industry Opportunities and Challenges Table 4. Implantable Drug Eluting Stent Industry Restraints Table 5. Global Implantable Drug Eluting Stent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Implantable Drug Eluting Stent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Implantable Drug Eluting Stent Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Implantable Drug Eluting Stent Sales Market Share by Manufacturers Table 9. Global Implantable Drug Eluting Stent Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Implantable Drug Eluting Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Implantable Drug Eluting Stent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Implantable Drug Eluting Stent Manufacturers, Product Type & Application Table 13. Global Implantable Drug Eluting Stent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Implantable Drug Eluting Stent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rapamycin Table 17. Major Manufacturers of Everolimus Table 18. Major Manufacturers of Paclitaxel Table 19. Major Manufacturers of Other Table 20. Global Implantable Drug Eluting Stent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Implantable Drug Eluting Stent Sales by Type (2021-2026) & (K Units) Table 22. Global Implantable Drug Eluting Stent Sales by Type (2027-2032) & (K Units) Table 23. Global Implantable Drug Eluting Stent Sales Market Share by Type (2021-2026) Table 24. Global Implantable Drug Eluting Stent Sales Market Share by Type (2027-2032) Table 25. Global Implantable Drug Eluting Stent Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Implantable Drug Eluting Stent Revenue by Type (2021-2026) & (K Units) Table 27. Global Implantable Drug Eluting Stent Revenue by Type (2027-2032) & (K Units) Table 28. Global Implantable Drug Eluting Stent Revenue Market Share by Type (2021-2026) Table 29. Global Implantable Drug Eluting Stent Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Coronary Table 31. Major Manufacturers of Peripheral Vascular Table 32. Major Manufacturers of Others Table 33. Global Implantable Drug Eluting Stent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Implantable Drug Eluting Stent Sales by Application (2021-2026) & (K Units) Table 35. Global Implantable Drug Eluting Stent Sales by Application (2027-2032) & (K Units) Table 36. Global Implantable Drug Eluting Stent Sales Market Share by Application (2021-2026) Table 37. Global Implantable Drug Eluting Stent Sales Market Share by Application (2027-2032) Table 38. Global Implantable Drug Eluting Stent Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Implantable Drug Eluting Stent Revenue by Application (2021-2026) & (K Units) Table 40. Global Implantable Drug Eluting Stent Revenue by Application (2027-2032) & (K Units) Table 41. Global Implantable Drug Eluting Stent Revenue Market Share by Application (2021-2026) Table 42. Global Implantable Drug Eluting Stent Revenue Market Share by Application (2027-2032) Table 43. Global Implantable Drug Eluting Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Implantable Drug Eluting Stent Sales by Region (2021-2026) & (K Units) Table 45. Global Implantable Drug Eluting Stent Sales Market Share by Region (2021-2026) Table 46. Global Implantable Drug Eluting Stent Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Implantable Drug Eluting Stent Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Implantable Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 50. North America Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 51. Europe Implantable Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 53. Europe Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Implantable Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Implantable Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 60. Global Implantable Drug Eluting Stent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Implantable Drug Eluting Stent Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Implantable Drug Eluting Stent Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Implantable Drug Eluting Stent Revenue Market Share by Region (2021-2026) Table 64. Global Implantable Drug Eluting Stent Revenue Market Share by Region (2027-2032) Table 65. Cook Company Information Table 66. Cook Business Overview Table 67. Cook Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Cook Implantable Drug Eluting Stent Product Portfolio Table 69. Cook Recent Development Table 70. Drug-eluting Stent Company Information Table 71. Drug-eluting Stent Business Overview Table 72. Drug-eluting Stent Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Drug-eluting Stent Implantable Drug Eluting Stent Product Portfolio Table 74. Drug-eluting Stent Recent Development Table 75. Terumo Company Information Table 76. Terumo Business Overview Table 77. Terumo Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Terumo Implantable Drug Eluting Stent Product Portfolio Table 79. Terumo Recent Development Table 80. Boston Scientific Company Information Table 81. Boston Scientific Business Overview Table 82. Boston Scientific Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Boston Scientific Implantable Drug Eluting Stent Product Portfolio Table 84. Boston Scientific Recent Development Table 85. Lepu Medical Company Information Table 86. Lepu Medical Business Overview Table 87. Lepu Medical Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Lepu Medical Implantable Drug Eluting Stent Product Portfolio Table 89. Lepu Medical Recent Development Table 90. Medtronic Company Information Table 91. Medtronic Business Overview Table 92. Medtronic Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Medtronic Implantable Drug Eluting Stent Product Portfolio Table 94. Medtronic Recent Development Table 95. Beijing Amsino Medical Company Information Table 96. Beijing Amsino Medical Business Overview Table 97. Beijing Amsino Medical Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Beijing Amsino Medical Implantable Drug Eluting Stent Product Portfolio Table 99. Beijing Amsino Medical Recent Development Table 100. SINOMED Company Information Table 101. SINOMED Business Overview Table 102. SINOMED Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. SINOMED Implantable Drug Eluting Stent Product Portfolio Table 104. SINOMED Recent Development Table 105. Microport Medical Company Information Table 106. Microport Medical Business Overview Table 107. Microport Medical Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Microport Medical Implantable Drug Eluting Stent Product Portfolio Table 109. Microport Medical Recent Development Table 110. Abbott Company Information Table 111. Abbott Business Overview Table 112. Abbott Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Abbott Implantable Drug Eluting Stent Product Portfolio Table 114. Abbott Recent Development Table 115. Yinyi Biotech Company Information Table 116. Yinyi Biotech Business Overview Table 117. Yinyi Biotech Implantable Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Yinyi Biotech Implantable Drug Eluting Stent Product Portfolio Table 119. Yinyi Biotech Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Implantable Drug Eluting Stent Distributors List Table 123. Implantable Drug Eluting Stent Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Implantable Drug Eluting Stent Product Image Figure 2. Global Implantable Drug Eluting Stent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Implantable Drug Eluting Stent Market Size (2021-2032) & (US$ Million) Figure 4. Global Implantable Drug Eluting Stent Sales (2021-2032) & (K Units) Figure 5. Global Implantable Drug Eluting Stent Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Implantable Drug Eluting Stent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rapamycin Image Figure 9. Everolimus Image Figure 10. Paclitaxel Image Figure 11. Other Image Figure 12. Global Implantable Drug Eluting Stent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Implantable Drug Eluting Stent Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Implantable Drug Eluting Stent Sales Market Share by Type (2021-2032) Figure 15. Global Implantable Drug Eluting Stent Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Implantable Drug Eluting Stent Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Implantable Drug Eluting Stent Revenue Market Share by Type (2021-2032) Figure 18. Coronary Image Figure 19. Peripheral Vascular Image Figure 20. Others Image Figure 21. Global Implantable Drug Eluting Stent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Implantable Drug Eluting Stent Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Implantable Drug Eluting Stent Sales Market Share by Application (2021-2032) Figure 24. Global Implantable Drug Eluting Stent Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Implantable Drug Eluting Stent Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Implantable Drug Eluting Stent Revenue Market Share by Application (2021-2032) Figure 27. North America Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 29. U.S. Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 34. Germany Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 41. China Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 49. Brazil Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Implantable Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Implantable Drug Eluting Stent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Implantable Drug Eluting Stent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Implantable Drug Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 60. North America Implantable Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Implantable Drug Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 62. Europe Implantable Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Implantable Drug Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Implantable Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Implantable Drug Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Implantable Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Implantable Drug Eluting Stent Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Implantable Drug Eluting Stent Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rapamycin
  • Everolimus
  • Paclitaxel
  • Other
Applications
  • Coronary
  • Peripheral Vascular
  • Others
Companies covered
  • Cook
  • Drug-eluting Stent
  • Terumo
  • Boston Scientific
  • Lepu Medical
  • Medtronic
  • Beijing Amsino Medical
  • SINOMED
  • Microport Medical
  • Abbott
  • Yinyi Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Implantable Drug Eluting Stent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Implantable Drug Eluting Stent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Implantable Drug Eluting Stent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Implantable Drug Eluting Stent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Implantable Drug Eluting Stent Market Dynamics
  1. 2.1 Implantable Drug Eluting Stent Industry Trends
  2. 2.2 Implantable Drug Eluting Stent Industry Drivers
  3. 2.3 Implantable Drug Eluting Stent Industry Opportunities and Challenges
  4. 2.4 Implantable Drug Eluting Stent Industry Restraints
3 Implantable Drug Eluting Stent Market by Manufacturers
  1. 3.1 Global Implantable Drug Eluting Stent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Implantable Drug Eluting Stent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Implantable Drug Eluting Stent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Implantable Drug Eluting Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Implantable Drug Eluting Stent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Implantable Drug Eluting Stent Manufacturers, Product Type & Application
  7. 3.7 Global Implantable Drug Eluting Stent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Implantable Drug Eluting Stent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Implantable Drug Eluting Stent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Implantable Drug Eluting Stent Tier 1, Tier 2, and Tier 3
4 Implantable Drug Eluting Stent Market by Type
  1. 4.1 Implantable Drug Eluting Stent Type Introduction
  2. 4.1.1 Rapamycin
  3. 4.1.2 Everolimus
  4. 4.1.3 Paclitaxel
  5. 4.1.4 Other
  6. 4.2 Global Implantable Drug Eluting Stent Sales by Type
  7. 4.2.1 Global Implantable Drug Eluting Stent Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Implantable Drug Eluting Stent Sales by Type (2021-2032)
  9. 4.2.3 Global Implantable Drug Eluting Stent Sales Market Share by Type (2021-2032)
  10. 4.3 Global Implantable Drug Eluting Stent Revenue by Type
  11. 4.3.1 Global Implantable Drug Eluting Stent Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Implantable Drug Eluting Stent Revenue by Type (2021-2032)
  13. 4.3.3 Global Implantable Drug Eluting Stent Revenue Market Share by Type (2021-2032)
5 Implantable Drug Eluting Stent Market by Application
  1. 5.1 Implantable Drug Eluting Stent Application Introduction
  2. 5.1.1 Coronary
  3. 5.1.2 Peripheral Vascular
  4. 5.1.3 Others
  5. 5.2 Global Implantable Drug Eluting Stent Sales by Application
  6. 5.2.1 Global Implantable Drug Eluting Stent Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Implantable Drug Eluting Stent Sales by Application (2021-2032)
  8. 5.2.3 Global Implantable Drug Eluting Stent Sales Market Share by Application (2021-2032)
  9. 5.3 Global Implantable Drug Eluting Stent Revenue by Application
  10. 5.3.1 Global Implantable Drug Eluting Stent Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Implantable Drug Eluting Stent Revenue by Application (2021-2032)
  12. 5.3.3 Global Implantable Drug Eluting Stent Revenue Market Share by Application (2021-2032)
6 Global Implantable Drug Eluting Stent Sales by Region
  1. 6.1 Global Implantable Drug Eluting Stent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Implantable Drug Eluting Stent Sales by Region (2021-2032)
  3. 6.2.1 Global Implantable Drug Eluting Stent Sales by Region (2021-2026)
  4. 6.2.2 Global Implantable Drug Eluting Stent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Implantable Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Implantable Drug Eluting Stent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Implantable Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Implantable Drug Eluting Stent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Implantable Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Implantable Drug Eluting Stent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Implantable Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Implantable Drug Eluting Stent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Implantable Drug Eluting Stent Revenue by Region
  1. 7.1 Global Implantable Drug Eluting Stent Revenue by Region
  2. 7.1.1 Global Implantable Drug Eluting Stent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Implantable Drug Eluting Stent Revenue by Region (2021-2026)
  4. 7.1.3 Global Implantable Drug Eluting Stent Revenue by Region (2027-2032)
  5. 7.1.4 Global Implantable Drug Eluting Stent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Implantable Drug Eluting Stent Revenue (2021-2032)
  8. 7.2.2 North America Implantable Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Implantable Drug Eluting Stent Revenue (2021-2032)
  11. 7.3.2 Europe Implantable Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Implantable Drug Eluting Stent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Implantable Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Implantable Drug Eluting Stent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Implantable Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cook
  2. 8.1.1 Cook Company Information
  3. 8.1.2 Cook Business Overview
  4. 8.1.3 Cook Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cook Implantable Drug Eluting Stent Product Portfolio
  6. 8.1.5 Cook Recent Developments
  7. 8.2 Drug-eluting Stent
  8. 8.2.1 Drug-eluting Stent Company Information
  9. 8.2.2 Drug-eluting Stent Business Overview
  10. 8.2.3 Drug-eluting Stent Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Drug-eluting Stent Implantable Drug Eluting Stent Product Portfolio
  12. 8.2.5 Drug-eluting Stent Recent Developments
  13. 8.3 Terumo
  14. 8.3.1 Terumo Company Information
  15. 8.3.2 Terumo Business Overview
  16. 8.3.3 Terumo Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Implantable Drug Eluting Stent Product Portfolio
  18. 8.3.5 Terumo Recent Developments
  19. 8.4 Boston Scientific
  20. 8.4.1 Boston Scientific Company Information
  21. 8.4.2 Boston Scientific Business Overview
  22. 8.4.3 Boston Scientific Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Implantable Drug Eluting Stent Product Portfolio
  24. 8.4.5 Boston Scientific Recent Developments
  25. 8.5 Lepu Medical
  26. 8.5.1 Lepu Medical Company Information
  27. 8.5.2 Lepu Medical Business Overview
  28. 8.5.3 Lepu Medical Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lepu Medical Implantable Drug Eluting Stent Product Portfolio
  30. 8.5.5 Lepu Medical Recent Developments
  31. 8.6 Medtronic
  32. 8.6.1 Medtronic Company Information
  33. 8.6.2 Medtronic Business Overview
  34. 8.6.3 Medtronic Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medtronic Implantable Drug Eluting Stent Product Portfolio
  36. 8.6.5 Medtronic Recent Developments
  37. 8.7 Beijing Amsino Medical
  38. 8.7.1 Beijing Amsino Medical Company Information
  39. 8.7.2 Beijing Amsino Medical Business Overview
  40. 8.7.3 Beijing Amsino Medical Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Amsino Medical Implantable Drug Eluting Stent Product Portfolio
  42. 8.7.5 Beijing Amsino Medical Recent Developments
  43. 8.8 SINOMED
  44. 8.8.1 SINOMED Company Information
  45. 8.8.2 SINOMED Business Overview
  46. 8.8.3 SINOMED Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SINOMED Implantable Drug Eluting Stent Product Portfolio
  48. 8.8.5 SINOMED Recent Developments
  49. 8.9 Microport Medical
  50. 8.9.1 Microport Medical Company Information
  51. 8.9.2 Microport Medical Business Overview
  52. 8.9.3 Microport Medical Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Microport Medical Implantable Drug Eluting Stent Product Portfolio
  54. 8.9.5 Microport Medical Recent Developments
  55. 8.10 Abbott
  56. 8.10.1 Abbott Company Information
  57. 8.10.2 Abbott Business Overview
  58. 8.10.3 Abbott Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Implantable Drug Eluting Stent Product Portfolio
  60. 8.10.5 Abbott Recent Developments
  61. 8.11 Yinyi Biotech
  62. 8.11.1 Yinyi Biotech Company Information
  63. 8.11.2 Yinyi Biotech Business Overview
  64. 8.11.3 Yinyi Biotech Implantable Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Yinyi Biotech Implantable Drug Eluting Stent Product Portfolio
  66. 8.11.5 Yinyi Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Implantable Drug Eluting Stent Value Chain Analysis
  2. 9.1.1 Implantable Drug Eluting Stent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Implantable Drug Eluting Stent Production Mode & Process
  6. 9.2 Implantable Drug Eluting Stent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Implantable Drug Eluting Stent Distributors
  9. 9.2.3 Implantable Drug Eluting Stent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst